ID30377A - Metoda pengobatan neurodegenerasi - Google Patents

Metoda pengobatan neurodegenerasi

Info

Publication number
ID30377A
ID30377A IDW00200102283A ID20012283A ID30377A ID 30377 A ID30377 A ID 30377A ID W00200102283 A IDW00200102283 A ID W00200102283A ID 20012283 A ID20012283 A ID 20012283A ID 30377 A ID30377 A ID 30377A
Authority
ID
Indonesia
Prior art keywords
treatment method
neurodegeneration
neurodegeneration treatment
treatment
Prior art date
Application number
IDW00200102283A
Other languages
English (en)
Indonesian (id)
Inventor
Eiichi Otomo
Yoshiyuki Takasu
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of ID30377A publication Critical patent/ID30377A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IDW00200102283A 2000-02-23 2001-02-23 Metoda pengobatan neurodegenerasi ID30377A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51195200A 2000-02-23 2000-02-23

Publications (1)

Publication Number Publication Date
ID30377A true ID30377A (id) 2001-11-29

Family

ID=24037094

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200102283A ID30377A (id) 2000-02-23 2001-02-23 Metoda pengobatan neurodegenerasi

Country Status (20)

Country Link
US (2) US6423739B1 (enExample)
EP (1) EP1171123B1 (enExample)
JP (1) JP2003523385A (enExample)
KR (1) KR20010110798A (enExample)
CN (1) CN1362877A (enExample)
AR (1) AR030551A1 (enExample)
AT (1) ATE336246T1 (enExample)
AU (1) AU784418B2 (enExample)
BR (1) BR0104586A (enExample)
CA (1) CA2368352C (enExample)
DE (1) DE60122252T2 (enExample)
DK (1) DK1171123T3 (enExample)
ES (1) ES2270981T3 (enExample)
HK (1) HK1047038A1 (enExample)
ID (1) ID30377A (enExample)
IL (1) IL145799A (enExample)
MX (1) MXPA01010749A (enExample)
NO (1) NO321911B1 (enExample)
TW (1) TWI289060B (enExample)
WO (1) WO2001062246A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077709A1 (en) * 1999-05-31 2004-04-22 Daiichi Pharmaceutical Co., Ltd. Neuronal death inhibitors
KR100823668B1 (ko) * 2000-12-28 2008-04-21 해밀턴 파마슈티컬스 인코포레이티드 신경성 통증 치료 및 예방약
ATE404192T1 (de) * 2001-08-22 2008-08-15 Hamilton Pharmaceuticals Inc Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
RU2205631C1 (ru) * 2002-06-19 2003-06-10 Закрытое акционерное общество "Брынцалов-А" Ноотропное средство "ноотобрил" в форме таблеток
US20060241144A1 (en) * 2005-04-20 2006-10-26 Albert Cha Method for treating apathy syndrome
ES2664727T3 (es) 2009-10-22 2018-04-23 University College Dublin National University Of Ireland, Dublin Terapia causal de enfermedades o estados asociados con desmielinización del SNC o del SNP
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2469995A (en) * 1946-07-23 1949-05-10 Schaul Martin Carl Process for the production of food preparations from potatoes and similar farinaceoustubers
US3031314A (en) * 1960-03-16 1962-04-24 Carl E Hendel Preparation of dehydrated potatoes
US3260607A (en) * 1961-02-07 1966-07-12 Canadian Patents Dev Preparation of dehydrated cooked mashed potato
US3968265A (en) * 1973-02-01 1976-07-06 American Potato Company Freeze-thaw stable, french fry potato product and process for producing the same
DE2923975A1 (de) 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2924011C2 (de) 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
IT1141287B (it) 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
SK279285B6 (sk) 1991-05-02 1998-09-09 Daiichi Pharmaceutical Co. Použitie n-(2,6-dimetylfenyl)-2-(2-oxo-1-pyrolidin
US5525058A (en) 1992-03-27 1996-06-11 American Dental Technologies, Inc. Dental treatment system
EP0785599B1 (en) 1995-07-10 2000-12-13 Kodera Electronics Co., Ltd. Device for inserting a wire to be worked on
US6107330A (en) 1995-08-07 2000-08-22 Daiichi Pharmaceutical Co., Ltd. Inhibitor for narcotic analgesic dependence/resistance acquisition
JP2002241272A (ja) 1996-07-18 2002-08-28 Mitsubishi Pharma Corp 医薬処方組成物
NZ333978A (en) 1996-07-30 2000-09-29 Henkel Ecolab Gmbh & Co Film-building agent for protecting teats and udders against infection after milking, comprising a film-forming component and disinfecting agents
KR20000048847A (ko) 1996-10-01 2000-07-25 스즈키 다다시 미토콘드리아 막 안정화제
US6211701B1 (en) 1996-12-16 2001-04-03 Rose Research, Llc Low power line switching circuit, device and method
IT1293533B1 (it) 1997-07-14 1999-03-01 Angeletti P Ist Richerche Bio Metodo per la selezione di molecole in grado di mimare, inibire o potenziare gli effetti della interazione tra leptina e cellule che
AU8131198A (en) 1997-07-15 1999-02-10 Daiichi Pharmaceutical Co., Ltd. Prophylactic or therapeutic agent for amnesia
JPH1180027A (ja) 1997-09-12 1999-03-23 Dai Ichi Seiyaku Co Ltd 向知性薬
TW544311B (en) 1998-08-06 2003-08-01 Daiichi Seiyaku Co Therapeutic or preventive agent for intractable epilepsies
CN1368882A (zh) 1999-05-31 2002-09-11 第一制药株式会社 神经元死亡抑制剂

Also Published As

Publication number Publication date
EP1171123A1 (en) 2002-01-16
US20020055534A1 (en) 2002-05-09
US6399650B2 (en) 2002-06-04
HK1047038A1 (zh) 2003-02-07
ES2270981T3 (es) 2007-04-16
MXPA01010749A (es) 2002-08-20
CA2368352C (en) 2009-11-10
NO20015162L (no) 2001-12-21
ATE336246T1 (de) 2006-09-15
KR20010110798A (ko) 2001-12-13
CA2368352A1 (en) 2001-08-30
DK1171123T3 (da) 2006-12-04
IL145799A0 (en) 2002-07-25
NO20015162D0 (no) 2001-10-22
AU3414501A (en) 2001-09-03
AU784418B2 (en) 2006-03-30
NO321911B1 (no) 2006-07-17
DE60122252T2 (de) 2007-07-05
US20010051653A1 (en) 2001-12-13
DE60122252D1 (de) 2006-09-28
CN1362877A (zh) 2002-08-07
AR030551A1 (es) 2003-08-27
EP1171123B1 (en) 2006-08-16
IL145799A (en) 2006-10-31
BR0104586A (pt) 2002-01-08
WO2001062246A1 (en) 2001-08-30
JP2003523385A (ja) 2003-08-05
TWI289060B (en) 2007-11-01
US6423739B1 (en) 2002-07-23

Similar Documents

Publication Publication Date Title
DK1267650T3 (da) Tobakbehandling
FI20000863L (fi) Uusi hoitomenetelmä
DE60028849D1 (de) Sterilisationsmethode
DE60117286D1 (de) Prozesssteuerung
DE60120276D1 (de) Laserbehandlungsgerät
DE60105229D1 (de) Laserbehandlungsgerät
DE60029553D1 (de) Schätzungsmethode
DE60121531D1 (de) Laserbehandlungsgerät
DE60137595D1 (de) Bilderzeugungsverfahren
DE60103427D1 (de) Übereinstimmungssteuerverfahren
DE60100737D1 (de) Laserbehandlungsgerät
NO20032122D0 (no) Forbedret behandling
ATE502118T1 (de) Amplifizierungsverfahren
DE10196082T1 (de) FLIP-CHIP-Montageverfahren
DK1281616T3 (da) Væskepåfyldningsmetode
PT102870A (pt) Metodo de tratamento de condensados
IS6716A (is) Aðferðir við að framleiða sílostasól
DE60140597D1 (de) Vakuumbehandlungsverfahren
NO20015162D0 (no) Fremgangsmåte for behandling av nevrodegenerering
NO20032563D0 (no) Filtreringsfremgangsmåte
GB0026838D0 (en) Treatment method
DE60226093D1 (de) Urmedium-Reinigungsmethode
DE50107729D1 (de) Regelverfahren
NO20022643D0 (no) Reduksjonsprosess
ITMI20001867A0 (it) Metodo di trattamento di reflui.